beta
Trial Radar AI
I can help you find nearby clinical trials and understand health conditions and treatments.
170 Results
Top 50 Showing
 
Status (Default)
Not yet Recruiting, Recruiting, Active, Not Recruiting
×
 
Keywords
Type 2 Diabetes Mellitus
×
 
Age Group
Older Adult
×
 
Intervention
GLP-1
×
 
Study Title
Status
Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy (DINE-GLP1) NCT07313384
Recruiting
GLP-1 RA on Liver OMICS in MASLD NCT06982378
Not yet recruiting
Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs (ICDDTKZ26) NCT07303556
Active, not recruiting
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists NCT07325435
Active, not recruiting
Impact GLP-1 Agonists Following Bariatric NCT06132477
Recruiting
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring NCT06668935
Recruiting
Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes (GLOW) NCT07428746
Not yet recruiting
Endoscopic Band Ligation for Type 2 Diabetes Mellitus (ENDOBAND-DM) NCT07117721
Not yet recruiting
Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial NCT07111494
Not yet recruiting
Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM NCT06256419
Recruiting
GLP1 Analogues and the Risk of Osteoarthritis NCT07360457
Not yet recruiting
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes (PRECIDENTD) NCT05390892
Recruiting
Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period. NCT06388213
Not yet recruiting
GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM (STABLE-GLP1) NCT07314684
Recruiting
Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk (SIPPA-QH_HHC-2) NCT07032311
Not yet recruiting
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study (CER-4-T2D) NCT05220917
Active, not recruiting
Semaglutide and Preoperative Residual Gastric Volumes NCT06263595
Recruiting
Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users (aGLP1-GUS) NCT06987669
Not yet recruiting
Beta-cell Response to Incretin Hormones in Cystic Fibrosis NCT01851694
Recruiting
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs (EXCEED) NCT05663515
Recruiting
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM (VESPER-2) NCT06897202
Active, not recruiting
Comparative Effectiveness of Empagliflozin in the US NCT03363464
Active, not recruiting
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants NCT06737042
Not yet recruiting
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes NCT06967558
Recruiting
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes NCT06976619
Recruiting
Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents NCT07307235
Not yet recruiting
The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination NCT03878706
Recruiting
Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes NCT06825182
Recruiting
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh NCT06449235
Not yet recruiting
Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes (DECLARED-CT) NCT06715514
Recruiting
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy NCT07502508
Recruiting
Autologous SVF Therapy for Type 2 Diabetes (LASER-DM2 Tria) NCT07487467
Recruiting
Comparison of Diabetes Patients - Care Trajectory Versus Convention NCT06577584
Not yet recruiting
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery NCT00992901
Recruiting
A Trial to Evaluate Safety, Feasibility and Efficacy of the ReCET Procedure (EMINENT-2) NCT05984238
Active, not recruiting
Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide (SEMA SMA) NCT06387199
Recruiting
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans NCT06972407
Not yet recruiting
GLP-1 RA for Stage 1 Type 1 Diabetes NCT07430332
Not yet recruiting
GLP1-RA and Periodontitis NCT07182123
Not yet recruiting
The Diabetes Staging System in Patient Aligned Care Teams NCT06142006
Recruiting
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes. (EPHIC-DIA2) NCT06851962
Active, not recruiting
Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 Diabetes NCT06706284
Recruiting
Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control (MESSAGE) NCT07244003
Recruiting
Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist (ARAY) NCT06851858
Active, not recruiting
Gut Hormones and Roux en Y Gastric Bypass NCT01945840
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) NCT07104383
Recruiting
A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 Diabetes (SEMPA) NCT06894784
Recruiting
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study) NCT07083154
Recruiting
CGM Use in Adults With Type 2 Diabetes on Basal Insulin NCT05944432
Active, not recruiting
Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist NCT06666049
Recruiting